ABCB1 and cancer: We have demonstrated that MDR1-positive cancer cells express constitutively COX-2 and that celecoxib, a specific inhibitor of COX-2 activity, can reverse drug resistance to apoptosis of these cells by a P-gp-dependent but COX-2-independent mechanism in MDR1-positive cells 15,16.